Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma
Interventional study of modulation of immune response in patients with pancreatic tubular adenocarcinoma after resection and gemcitabine treatment. When included, patients are pre-treated with moderate doses of cyclophosphamide. Then infusions of allogeneic mononuclear cells are given.
Pancreatic Tubular Adenocarcinoma
BIOLOGICAL: MIS
PROGRESSION FREE SURVIVAL, 1 YEAR
Interventional study of modulation of immune response in patients with pancreatic tubular adenocarcinoma after resection and gemcitabine treatment. When included, patients are pre-treated with moderate doses of cyclophosphamide. Then infusions of allogeneic mononuclear cells are given.